XML 40 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Disaggregated Revenues (Tables)
 3 Months Ended
Mar. 31, 2024
Disaggregation of Revenue [Abstract]  
Summary of disaggregation of revenues by nature
The following table summarizes the disaggregation of revenues by product or source, (dollars in thousands):
Three Months Ended
March 31,
20242023
(unaudited)
Net product sales
Qelbree$45,104 $25,782 
Oxtellar XR26,943 28,915 
GOCOVRI26,562 26,010 
APOKYN16,649 17,209 
Trokendi XR15,989 34,790 
Other(1)
7,214 7,869 
Total net product sales$138,461 $140,575 
Royalty and licensing revenues5,183 13,189 
Total revenues$143,644 $153,764 
___________________________________________
(1) Includes net product sales of MYOBLOC, XADAGO and Osmolex ER.
The following table shows the percentage of net product sales to total net product sales:

Percentage of Net Product Sales
Three Months Ended March 31,
20242023
(unaudited)
Qelbree33%18%
Oxtellar XR19%21%
GOCOVRI19%18%
APOKYN12%12%
Trokendi XR12%25%
Other(1)
5%6%
Total100%100%
___________________________________________
(1) Includes net product sales of MYOBLOC, XADAGO and Osmolex ER.